• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大流行 2009 年甲型 H1N1 流感感染的临床管理。

Clinical management of pandemic 2009 influenza A(H1N1) infection.

机构信息

Division of Respiratory Medicine, The Chinese University of Hong Kong, 9/F, Prince of Wales Hospital, 30-32 Ngan Shing St, Shatin, New Territories, Hong Kong.

出版信息

Chest. 2010 Apr;137(4):916-25. doi: 10.1378/chest.09-2344. Epub 2009 Dec 18.

DOI:10.1378/chest.09-2344
PMID:20022969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7094244/
Abstract

Antiviral therapy and vaccination are important strategies for controlling pandemic 2009 influenza A(H1N1) but efficacy depends on the timing of administration and is often limited by supply shortage. Patients with dyspnea, tachypnea, evidence of hypoxemia, and pulmonary infiltrates on chest radiograph should be hospitalized. Patients with severe illness or underlying medical conditions that increase the risk of more severe disease should be treated with oseltamivir or zanamivir as soon as possible, without waiting for the results of laboratory tests. Lung-protective ventilation strategy with a low tidal volume and adequate pressure, in addition to a conservative fluid management approach, is recommended when treating adult patients with ARDS. Extracorporeal membrane oxygenation has emerged as an important rescue therapy for critically ill patients. Use of systemic steroids was associated with delayed viral clearance in severe acute respiratory syndrome and H3N2 infection. Low-dose corticosteroids may be considered in the treatment of refractory septic shock. Passive immunotherapy in the form of convalescent plasma or hyperimmune globulin may be explored as rescue therapy. More data are needed to explore the potential role of IV gamma globulin and other drugs with immunomodulating properties, such as statins, gemfibrozil, and N-acetyl-cysteine. Health-care workers must apply strict standard and droplet precautions when dealing with suspected and confirmed case and upgrade to airborne precautions when performing aerosol-generating procedures. Nonpharmacologic measures, such as early case isolation, household quarantine, school/workplace closure, good community hygiene, and restrictions on travel are useful measures in controlling an influenza pandemic at its early phase.

摘要

抗病毒治疗和疫苗接种是控制大流行 2009 年甲型 H1N1 流感的重要策略,但疗效取决于给药时机,并且常常受到供应短缺的限制。有呼吸困难、呼吸急促、低氧血症证据和胸片肺部浸润的患者应住院治疗。有严重疾病或增加疾病严重程度风险的潜在医疗条件的患者应尽快接受奥司他韦或扎那米韦治疗,而无需等待实验室检测结果。对于患有 ARDS 的成年患者,建议采用低潮气量和足够压力的肺保护性通气策略,以及保守的液体管理方法。体外膜氧合已成为危重症患者的重要抢救治疗方法。在严重急性呼吸综合征和 H3N2 感染中,全身使用皮质类固醇与病毒清除延迟有关。在治疗难治性感染性休克时,可以考虑使用低剂量皮质类固醇。可以探索恢复期血浆或高免疫球蛋白等被动免疫疗法作为抢救治疗。需要更多的数据来探索 IV 免疫球蛋白和其他具有免疫调节特性的药物(如他汀类药物、吉非贝齐和 N-乙酰半胱氨酸)的潜在作用。医护人员在处理疑似和确诊病例时必须采取严格的标准和飞沫预防措施,在进行气溶胶生成操作时升级为空气传播预防措施。在流感大流行的早期阶段,非药物措施,如早期病例隔离、家庭检疫、学校/工作场所关闭、良好的社区卫生和旅行限制,是控制流感大流行的有用措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/7094244/5497a6d90233/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/7094244/8ff09fe02e0d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/7094244/1d4e97f04c5f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/7094244/5497a6d90233/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/7094244/8ff09fe02e0d/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/7094244/1d4e97f04c5f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc6c/7094244/5497a6d90233/gr3_lrg.jpg

相似文献

1
Clinical management of pandemic 2009 influenza A(H1N1) infection.大流行 2009 年甲型 H1N1 流感感染的临床管理。
Chest. 2010 Apr;137(4):916-25. doi: 10.1378/chest.09-2344. Epub 2009 Dec 18.
2
Influenza A/H5N1 infection: other treatment options and issues.甲型H5N1流感感染:其他治疗选择与问题
Respirology. 2008 Mar;13 Suppl 1:S22-6. doi: 10.1111/j.1440-1843.2008.01250.x.
3
[Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit].[西班牙重症与危重症医学及冠心病监护病房学会(SEMICYUC)传染病工作组(GTEI)以及西班牙传染病与临床微生物学会(SEIMC)危重症患者感染研究组(GEIPC)关于入住重症监护病房的重症成年甲型H1N1流感患者诊断和治疗的建议]
Med Intensiva. 2012 Mar;36(2):103-37. doi: 10.1016/j.medin.2011.11.020. Epub 2012 Jan 13.
4
Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A.体外膜肺氧合治疗 2009 年 H1N1 流感病毒导致的严重难治性呼吸衰竭
Respir Care. 2011 Jul;56(7):941-6. doi: 10.4187/respcare.01066. Epub 2011 Feb 21.
5
Evaluation of droplet dispersion during non-invasive ventilation, oxygen therapy, nebuliser treatment and chest physiotherapy in clinical practice: implications for management of pandemic influenza and other airborne infections.评估临床实践中无创通气、氧疗、雾化治疗和胸部物理治疗期间的飞沫扩散:对大流行性流感和其他空气传播感染的管理的影响。
Health Technol Assess. 2010 Oct;14(46):131-172. doi: 10.3310/hta14460-02.
6
[Clinical features of, treatments and preventions for newborns with pandemic influenza A (H1N1) 2009].2009年甲型H1N1流感大流行新生儿的临床特征、治疗与预防
Nihon Rinsho. 2010 Sep;68(9):1656-8.
7
Portable miniaturized extracorporeal membrane oxygenation systems for H1N1-related severe acute respiratory distress syndrome: a case series.便携式微型体外膜肺氧合系统治疗 H1N1 相关严重急性呼吸窘迫综合征:病例系列。
J Crit Care. 2012 Oct;27(5):454-63. doi: 10.1016/j.jcrc.2012.01.008. Epub 2012 Mar 3.
8
Fatal Acute Respiratory Distress Syndrome Due to Influenza A (H1N1) Infection in Patients After Kidney Transplantation: A Report of Five Cases.肾移植术后甲型流感(H1N1)感染所致的致命性急性呼吸窘迫综合征:5例报告
Ann Transplant. 2018 Mar 30;23:218-223. doi: 10.12659/AOT.907083.
9
Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada.加拿大因感染 2009 年甲型 H1N1 流感而发生严重呼吸衰竭的患者接受体外肺支持治疗。
Can J Anaesth. 2010 Mar;57(3):240-7. doi: 10.1007/s12630-009-9253-0. Epub 2010 Jan 16.
10
Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.在接受机械通气和体外膜肺氧合治疗的甲型H1N1流感危重症患者中,口服奥司他韦与吸入扎那米韦联合抗病毒治疗失败。
Scand J Infect Dis. 2011 Jul;43(6-7):495-503. doi: 10.3109/00365548.2011.556144. Epub 2011 Feb 10.

引用本文的文献

1
Establishment of a Risk Score Model for Early Prediction of Severe H1N1 Influenza.建立一个风险评分模型,用于早期预测严重 H1N1 流感。
Front Cell Infect Microbiol. 2022 Jan 4;11:776840. doi: 10.3389/fcimb.2021.776840. eCollection 2021.
2
Six-Month Outcomes of Post-ARDS Pulmonary Fibrosis in Patients With H1N1 Pneumonia.H1N1肺炎患者ARDS后肺纤维化的六个月结局
Front Mol Biosci. 2021 Jun 8;8:640763. doi: 10.3389/fmolb.2021.640763. eCollection 2021.
3
Pandemic 2009 influenza A (H1N1)-associated deaths among children in China: A retrospective analysis.

本文引用的文献

1
Epidemiological summary of pandemic influenza A (H1N1) 2009 virus - Ontario, Canada, June 2009.2009年甲型H1N1流感大流行病毒的流行病学总结 - 加拿大安大略省,2009年6月
Wkly Epidemiol Rec. 2009 Nov 20;84(47):485-91.
2
H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment.甲型 H1N1 流感病毒相关性急性肺损伤:奥司他韦联合长期皮质类固醇治疗的反应。
Intensive Care Med. 2010 Jan;36(1):33-41. doi: 10.1007/s00134-009-1727-6. Epub 2009 Nov 19.
3
The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza.
中国儿童2009年甲型H1N1流感大流行相关死亡情况:一项回顾性分析。
Pediatr Investig. 2018 Oct 17;2(3):166-171. doi: 10.1002/ped4.12053. eCollection 2018 Sep.
4
Helmet CPAP revisited in COVID-19 pneumonia: A case series.新冠病毒肺炎中头盔式持续气道正压通气的再探讨:病例系列
Can J Respir Ther. 2020 Jul 23;56:32-34. doi: 10.29390/cjrt-2020-019. eCollection 2020.
5
Quantitative Proteomics Analysis of Systemic Responses and Biological Mechanisms of ShuFengJieDu Capsule Using H1N1-Infected RAW264.7 Cells.基于H1N1感染的RAW264.7细胞对疏风解毒胶囊全身反应及生物学机制的定量蛋白质组学分析
ACS Omega. 2020 Jun 18;5(25):15417-15423. doi: 10.1021/acsomega.0c01545. eCollection 2020 Jun 30.
6
Aerosol Barrier Hood for Use in the Management of Critically Ill Adults With COVID-19.用于管理患有新冠肺炎的危重症成人患者的气溶胶屏障头罩
Ann Emerg Med. 2020 Sep;76(3):370-371. doi: 10.1016/j.annemergmed.2020.04.030. Epub 2020 Apr 22.
7
The airborne transmission of infection between flats in high-rise residential buildings: A review.高层住宅建筑中公寓间感染的空气传播:综述
Build Environ. 2015 Dec;94:516-531. doi: 10.1016/j.buildenv.2015.09.026. Epub 2015 Sep 30.
8
Wind tunnel tests of inter-flat pollutant transmission characteristics in a rectangular multi-storey residential building, part A: Effect of wind direction.矩形多层住宅建筑中扁平污染物传输特性的风洞试验,A部分:风向的影响。
Build Environ. 2016 Nov 1;108:159-170. doi: 10.1016/j.buildenv.2016.08.032. Epub 2016 Aug 30.
9
Outcome of Critically Ill Patients With Influenza Infection: A Retrospective Study.流感感染重症患者的结局:一项回顾性研究
Infect Dis (Auckl). 2020 Feb 6;13:1178633720904081. doi: 10.1177/1178633720904081. eCollection 2020.
10
Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome.中东呼吸综合征危重症患者的无创通气。
Influenza Other Respir Viruses. 2019 Jul;13(4):382-390. doi: 10.1111/irv.12635. Epub 2019 Mar 18.
帕拉米韦用于治疗2009年甲型H1N1流感的紧急使用授权。
N Engl J Med. 2009 Dec 3;361(23):2204-7. doi: 10.1056/NEJMp0910479. Epub 2009 Nov 2.
4
Lung pathology in fatal novel human influenza A (H1N1) infection.新型致命性人感染甲型 H1N1 流感的肺部病理学改变。
Am J Respir Crit Care Med. 2010 Jan 1;181(1):72-9. doi: 10.1164/rccm.200909-1420OC. Epub 2009 Oct 29.
5
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome.体外膜肺氧合治疗2009年甲型H1N1流感所致急性呼吸窘迫综合征
JAMA. 2009 Nov 4;302(17):1888-95. doi: 10.1001/jama.2009.1535. Epub 2009 Oct 12.
6
Critically ill patients with 2009 influenza A(H1N1) infection in Canada.加拿大2009年甲型H1N1流感感染的重症患者。
JAMA. 2009 Nov 4;302(17):1872-9. doi: 10.1001/jama.2009.1496. Epub 2009 Oct 12.
7
Critical care services and 2009 H1N1 influenza in Australia and New Zealand.澳大利亚和新西兰的重症监护服务与2009年甲型H1N1流感
N Engl J Med. 2009 Nov 12;361(20):1925-34. doi: 10.1056/NEJMoa0908481. Epub 2009 Oct 8.
8
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.2009年4月至6月在美国住院治疗的2009年甲型H1N1流感患者。
N Engl J Med. 2009 Nov 12;361(20):1935-44. doi: 10.1056/NEJMoa0906695. Epub 2009 Oct 8.
9
Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City.2009年甲型H1N1大流行性流感季节性三价灭活疫苗的部分保护作用:墨西哥城的病例对照研究
BMJ. 2009 Oct 6;339:b3928. doi: 10.1136/bmj.b3928.
10
Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) - United States, May-August 2009.2009年甲型H1N1流感大流行致死病例肺组织标本中的细菌合并感染 - 美国,2009年5月至8月
MMWR Morb Mortal Wkly Rep. 2009 Oct 2;58(38):1071-4.